Trials / Conditions / Mismatch Repair Deficient or MSI-High Solid Tumors
Mismatch Repair Deficient or MSI-High Solid Tumors
4 registered clinical trials studyying Mismatch Repair Deficient or MSI-High Solid Tumors — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Factors Influencing Immunotherapy Response in dMMR/MSI-H Gastric/Gastroesophageal Junction Adenocarcinoma NCT07259473 | Shanghai Zhongshan Hospital | Phase 2 |
| Not Yet Recruiting | Adebrelimab Combined With Induction Chemotherapy or SHR-8068 for Mismatch Repair-Deficient/Microsatellite Inst NCT07266025 | Shanghai Zhongshan Hospital | Phase 2 |
| Recruiting | EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in NCT07262619 | Eikon Therapeutics | Phase 1 / Phase 2 |
| Completed | SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas NCT03894618 | Shattuck Labs, Inc. | Phase 1 |